Co Diagnostics Stock Buy Hold or Sell Recommendation

CODX
 Stock
  

USD 6.72  0.29  4.14%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Co-Diagnostics is 'Strong Buy'. Macroaxis provides Co Diagnostics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CODX positions. The advice algorithm takes into account all of Co Diagnostics' available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Co Diagnostics' buy-and-hold perspective. Continue to Co Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Co Diagnostics and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Co-Diagnostics.

Execute Co Diagnostics Buy or Sell Advice

The Co Diagnostics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Co-Diagnostics. Macroaxis does not own or have any residual interests in Co-Diagnostics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Co Diagnostics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Co DiagnosticsBuy Co Diagnostics
Strong Buy

Volatility

Somewhat reliableDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Below AverageDetails

Economic Sensitivity

Actively responds to the marketDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Co-Diagnostics has a Risk Adjusted Performance of 0.2197, Jensen Alpha of 0.8051, Total Risk Alpha of 0.9025, Sortino Ratio of 0.206 and Treynor Ratio of 0.4224
We provide trade recommendation to complement the latest expert consensus on Co-Diagnostics. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available today. To make sure Co-Diagnostics is not overpriced, please confirm all Co-Diagnostics fundamentals, including its cash and equivalents, beta, and the relationship between the price to sales and book value per share . Given that Co-Diagnostics has a number of shares shorted of 1.72 M, we suggest you to validate Co Diagnostics market performance and probability of bankruptcy to ensure the company can sustain itself for few more years given your latest risk tolerance and investing horizon.

Co Diagnostics Trading Alerts and Improvement Suggestions

Co-Diagnostics appears to be risky and price may revert if volatility continues
Co-Diagnostics has a poor financial position based on the latest SEC disclosures
Latest headline from www.fool.com: Should You Really Care About This Companys Short-Term Success - The Motley Fool

Co Diagnostics current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Co Diagnostics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Co Diagnostics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price18.33
Target Median Price14.00
Target High Price29.00
Recommendation Mean1.70
Number Of Analyst Opinions3
Target Low Price12.00
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Co Diagnostics Returns Distribution Density

The distribution of Co Diagnostics' historical returns is an attempt to chart the future uncertainty of Co Diagnostics' future price movements. The chart of the probability distribution of Co Diagnostics stock daily returns describes the distribution of returns around its average expected value. We use Co-Diagnostics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Co Diagnostics returns is essential to provide solid investment advice for Co Diagnostics stock.
Mean Return0.72Value At Risk-5.6
Potential Upside7.34Standard Deviation4.43
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Co Diagnostics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Co Diagnostics Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(129.31 K)(41.34 K)(113.25 K)(774.4 K)(669.46 K)(687.08 K)
Depreciation Amortization and Accretion45.76 K50.77 K65.9 K138.63 K335.36 K361.84 K
Net Cash Flow or Change in Cash and Cash Equivalents2.54 M(2.58 M)(57.1 K)42.08 M45.63 M49.23 M
Net Cash Flow from Financing5.94 M1.88 M5.9 M19.74 M450.4 K462.25 K
Net Cash Flow from Investing(189.31 K)(380.34 K)(435.25 K)(5.82 M)4.1 M4.42 M
Net Cash Flow from Operations(3.21 M)(4.08 M)(5.53 M)28.17 M41.08 M44.32 M
Share Based Compensation2.03 M1.33 M1.09 M2.74 M5.51 M5.94 M

Co Diagnostics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Co Diagnostics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Co Diagnostics stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Co Diagnostics stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.81
β
Beta against DOW1.68
σ
Overall volatility
4.36
Ir
Information ratio 0.17

Co Diagnostics Volatility Alert

Co-Diagnostics shows above-average downside volatility for the selected time horizon. We advise investors to inspect Co-Diagnostics further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Co Diagnostics future alpha. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Co Diagnostics' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Co Diagnostics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Co Diagnostics Implied Volatility

Co Diagnostics' implied volatility" href="/stock-options/CODX/Co-Diagnostics">Co Diagnostics' implied volatility exposes the market's sentiment of Co-Diagnostics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Co Diagnostics' implied volatility" href="/stock-options/CODX/Co-Diagnostics">Co Diagnostics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Co Diagnostics stock will not fluctuate a lot when Co Diagnostics' options" href="/stock-options/CODX/Co-Diagnostics">Co Diagnostics' options are near their expiration.

Co Diagnostics Fundamentals Vs Peers

Comparing Co Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Co Diagnostics' direct or indirect competition across all of the common fundamentals between Co Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Co Diagnostics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Co Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Co Diagnostics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Co Diagnostics to competition
FundamentalsCo DiagnosticsPeer Average
Return On Equity36.14 %(0.31) %
Return On Asset22.57 %(0.14) %
Profit Margin40.25 %(1.27) %
Operating Margin45.81 %(5.51) %
Current Valuation126.1 M16.62 B
Shares Outstanding29.16 M571.82 M
Shares Owned by Insiders0.43 %10.09 %
Shares Owned by Institutions20.86 %39.21 %
Number of Shares Shorted1.72 M4.71 M
Price to Earning4.78 X28.72 X
Price to Book1.96 X9.51 X
Price to Sales1.97 X11.42 X
Revenue100.56 M9.43 B
Gross Profit86.31 M27.38 B
EBITDA46.07 M3.9 B
Net Income40.47 M570.98 M
Cash and Equivalents97.42 M2.7 B
Cash per Share2.87 X5.01 X
Total Debt558.97 K5.32 B
Debt to Equity0.003 %48.70 %
Current Ratio9.63 X2.16 X
Book Value Per Share3.47 X1.93 K
Cash Flow from Operations36.62 M971.22 M
Short Ratio4.05 X4.00 X
Earnings Per Share1.42 X3.12 X
Number of Employees10118.84 K
Beta-1.09-0.15
Market Capitalization198.29 M19.03 B
Total Asset964.71 K29.47 B
Retained Earnings(25.62 M)9.33 B
Working Capital(1.98 M)1.48 B
Current Asset858.78 K9.34 B
Current Liabilities2.84 M7.9 B
   Acquisition by Eugene Durenard of 70000 shares of Co Diagnostics subject to Rule 16b-3 [view details]

Co Diagnostics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Co Diagnostics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution3049.37
Daily Balance Of Power(1.07)
Rate Of Daily Change0.96
Day Median Price6.82
Day Typical Price6.78
Market Facilitation Index0.0
Price Action Indicator(0.24)

About Co Diagnostics Buy or Sell Advice

When is the right time to buy or sell Co-Diagnostics? Buying financial instruments such as Co Diagnostics Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Co Diagnostics investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Current Assets1.58 M67.81 M115.12 M124.21 M
Total Assets2.22 M71.24 M160.03 M172.67 M

Use Investing Ideas to Build Portfolios

In addition to having Co Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Shipping Containers Thematic Idea Now

Shipping Containers
Shipping Containers Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipping Containers theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipping Containers Theme or any other thematic opportunities.
View All  Next Launch
Continue to Co Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Co-Diagnostics information on this page should be used as a complementary analysis to other Co Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Co Diagnostics Stock analysis

When running Co-Diagnostics price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Is Co Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Co Diagnostics. If investors know Co Diagnostics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Co Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.31
Market Capitalization
229.7 M
Quarterly Revenue Growth YOY
0.13
Return On Assets
0.23
Return On Equity
0.36
The market value of Co-Diagnostics is measured differently than its book value, which is the value of Co Diagnostics that is recorded on the company's balance sheet. Investors also form their own opinion of Co Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Co Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Co Diagnostics' market value can be influenced by many factors that don't directly affect Co Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Co Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Co Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Co Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.